These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16633150)

  • 1. Time course of in vivo 5-HTT transporter occupancy by fluvoxamine.
    Takano A; Suhara T; Ichimiya T; Yasuno F; Suzuki K
    J Clin Psychopharmacol; 2006 Apr; 26(2):188-91. PubMed ID: 16633150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter.
    Saijo T; Maeda J; Okauchi T; Maeda J; Morio Y; Kuwahara Y; Suzuki M; Goto N; Suzuki K; Higuchi M; Suhara T
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1021-32. PubMed ID: 19236731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.
    Suhara T; Takano A; Sudo Y; Ichimiya T; Inoue M; Yasuno F; Ikoma Y; Okubo Y
    Arch Gen Psychiatry; 2003 Apr; 60(4):386-91. PubMed ID: 12695316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupancy of serotonin transporter by tramadol: a positron emission tomography study with [11C]DASB.
    Ogawa K; Tateno A; Arakawa R; Sakayori T; Ikeda Y; Suzuki H; Okubo Y
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):845-50. PubMed ID: 24423243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
    Kim JS; Ichise M; Sangare J; Innis RB
    J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
    Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
    Cannon DM; Ichise M; Fromm SJ; Nugent AC; Rollis D; Gandhi SK; Klaver JM; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2006 Aug; 60(3):207-17. PubMed ID: 16875929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography.
    Parsey RV; Kent JM; Oquendo MA; Richards MC; Pratap M; Cooper TB; Arango V; Mann JJ
    Biol Psychiatry; 2006 May; 59(9):821-8. PubMed ID: 16213473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.
    Hesse S; Rullmann M; Luthardt J; Winter K; Hankir MK; Becker GA; Zientek F; Reissig G; Regenthal R; Drabe M; Schinke C; Bresch A; Arelin K; Lobsien D; Patt M; Meyer PM; Fasshauer M; Fenske WK; Blüher M; Stumvoll M; Sabri O
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1096-104. PubMed ID: 26577939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.
    Meyer JH
    J Psychiatry Neurosci; 2007 Mar; 32(2):86-102. PubMed ID: 17353938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-finding study of duloxetine based on serotonin transporter occupancy.
    Takano A; Suzuki K; Kosaka J; Ota M; Nozaki S; Ikoma Y; Tanada S; Suhara T
    Psychopharmacology (Berl); 2006 Apr; 185(3):395-9. PubMed ID: 16506079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronopharmacological study of antidepressants in forced swimming test of mice.
    Ushijima K; Sakaguchi H; Sato Y; To H; Koyanagi S; Higuchi S; Ohdo S
    J Pharmacol Exp Ther; 2005 Nov; 315(2):764-70. PubMed ID: 16079297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography.
    Spies M; James GM; Berroterán-Infante N; Ibeschitz H; Kranz GS; Unterholzner J; Godbersen M; Gryglewski G; Hienert M; Jungwirth J; Pichler V; Reiter B; Silberbauer L; Winkler D; Mitterhauser M; Stimpfl T; Hacker M; Kasper S; Lanzenberger R
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):145-153. PubMed ID: 29045739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between neuroticism personality trait and serotonin transporter binding.
    Takano A; Arakawa R; Hayashi M; Takahashi H; Ito H; Suhara T
    Biol Psychiatry; 2007 Sep; 62(6):588-92. PubMed ID: 17336939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
    Bhagwagar Z; Murthy N; Selvaraj S; Hinz R; Taylor M; Fancy S; Grasby P; Cowen P
    Am J Psychiatry; 2007 Dec; 164(12):1858-65. PubMed ID: 18056241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-course of serotonin transporter occupancy by single dose of three SSRIs in human brain: A positron emission tomography study with [(11)C]DASB.
    Arakawa R; Tateno A; Kim W; Sakayori T; Ogawa K; Okubo Y
    Psychiatry Res Neuroimaging; 2016 May; 251():1-6. PubMed ID: 27082864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortex.
    Geldof M; Freijer JI; van Beijsterveldt L; Langlois X; Danhof M
    Br J Pharmacol; 2008 Jul; 154(6):1369-78. PubMed ID: 18493251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proof of mechanism study of a novel serotonin transporter blocker, DA-8031, using [11C]DASB positron emission tomography and in vivo microdialysis.
    Park HS; Jung IS; Lim NH; Sung JH; Lee S; Moon BS; Lee BC; Kang KK; Kim SE
    Urology; 2014 Jul; 84(1):245.e1-7. PubMed ID: 24824409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.